Cargando…

Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients

IN: Background and Aim: Infection of Toxoplasma gondii is a worldwide distribution. Toxoplasmosis in patients who are immunocompromised by virtue of underlying leukemia disease has received relatively little attention. This study was aimed to evaluate IgG and IgM antibodies of T. gondii and to minim...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharavi, Mohammad Javad, Roozbehani, Mona, Mandeh, Zienat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Veterinary World 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639104/
https://www.ncbi.nlm.nih.gov/pubmed/29062195
http://dx.doi.org/10.14202/vetworld.2017.1063-1065
_version_ 1783270826152296448
author Gharavi, Mohammad Javad
Roozbehani, Mona
Mandeh, Zienat
author_facet Gharavi, Mohammad Javad
Roozbehani, Mona
Mandeh, Zienat
author_sort Gharavi, Mohammad Javad
collection PubMed
description IN: Background and Aim: Infection of Toxoplasma gondii is a worldwide distribution. Toxoplasmosis in patients who are immunocompromised by virtue of underlying leukemia disease has received relatively little attention. This study was aimed to evaluate IgG and IgM antibodies of T. gondii and to minimize the role of T. gondii and opportunistic infection complication at the early stage of infection in leukemia patients. MATERIALS AND METHODS: The purpose of this assay was to measure anti-T. gondii IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA) technique in leukemia patients. RESULTS: IgG antibodies against T. gondii were detected by ELISA in 96 (56.4%) leukemia patients and 72 (42.4%) control group. IgM antibodies were found in 10 patients (5.9%) with leukemia and 3 (1.8%) in the corresponding. CONCLUSION: Our finding indicated that leukemia patients under immunosuppressive condition should not be neglected. Toxoplasmosis in leukemia patients as a main risk factor is considered, meanwhile in some patients, due to possibility of the presence of secondary infection that leads to severe toxoplasmosis.
format Online
Article
Text
id pubmed-5639104
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Veterinary World
record_format MEDLINE/PubMed
spelling pubmed-56391042017-10-23 Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients Gharavi, Mohammad Javad Roozbehani, Mona Mandeh, Zienat Vet World Research Article IN: Background and Aim: Infection of Toxoplasma gondii is a worldwide distribution. Toxoplasmosis in patients who are immunocompromised by virtue of underlying leukemia disease has received relatively little attention. This study was aimed to evaluate IgG and IgM antibodies of T. gondii and to minimize the role of T. gondii and opportunistic infection complication at the early stage of infection in leukemia patients. MATERIALS AND METHODS: The purpose of this assay was to measure anti-T. gondii IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA) technique in leukemia patients. RESULTS: IgG antibodies against T. gondii were detected by ELISA in 96 (56.4%) leukemia patients and 72 (42.4%) control group. IgM antibodies were found in 10 patients (5.9%) with leukemia and 3 (1.8%) in the corresponding. CONCLUSION: Our finding indicated that leukemia patients under immunosuppressive condition should not be neglected. Toxoplasmosis in leukemia patients as a main risk factor is considered, meanwhile in some patients, due to possibility of the presence of secondary infection that leads to severe toxoplasmosis. Veterinary World 2017-09 2017-09-13 /pmc/articles/PMC5639104/ /pubmed/29062195 http://dx.doi.org/10.14202/vetworld.2017.1063-1065 Text en Copyright: © Gharavi, et al. http://creativecommons.org/licenses/by/4.0 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gharavi, Mohammad Javad
Roozbehani, Mona
Mandeh, Zienat
Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
title Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
title_full Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
title_fullStr Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
title_full_unstemmed Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
title_short Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
title_sort detection of anti-toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639104/
https://www.ncbi.nlm.nih.gov/pubmed/29062195
http://dx.doi.org/10.14202/vetworld.2017.1063-1065
work_keys_str_mv AT gharavimohammadjavad detectionofantitoxoplasmagondiiantibodiesinchronicmyeloidleukemiaandacutemyeloidleukemiapatients
AT roozbehanimona detectionofantitoxoplasmagondiiantibodiesinchronicmyeloidleukemiaandacutemyeloidleukemiapatients
AT mandehzienat detectionofantitoxoplasmagondiiantibodiesinchronicmyeloidleukemiaandacutemyeloidleukemiapatients